<DOC>
	<DOCNO>NCT00999583</DOCNO>
	<brief_summary>The investigator hypothesise neuroprotective effect erythropoietin analogue could lead improve outcome cardiac arrest . To test hypothesis , investigator design randomize , multicentre , simple blind trial participate patient receive usual treatment 50 % also receive high dose epoetin alpha ( analogue erythropoietin ) `` add '' fashion . The main end point proportion patient arm reach day 60 best level recovery , use 5 level score .</brief_summary>
	<brief_title>High Dose Erythropoietin Analogue After Cardiac Arrest</brief_title>
	<detailed_description>Rationale : A recent pilot study show encouraging result regard potentially beneficial effect high dose epoetin alpha ( analogue erythropoietin ) administer early cardiac arrest . In open label non randomize trial , high proportion patient survive without significant cerebral disability without experience severe adverse event ( CARIOU et al . Resuscitation 2008 ) . Efficiency treatment evaluate randomized trial . Hypotheses : An early administration high dose epoetin alpha ( Epo ) cardiac arrest resuscitation could improve neurological outcome patient comparison standard treatment . The proportion patient reach level 1 Pittsburgh CPC scale ( i.e. , minor cerebral disability ) day 60 could attain 45 % interventional group versus 30 % expect control group . Design : Multicentre , randomise , control , simple blind trial ( `` add study '' ) . Main goal : To test efficiency high dose Epo administer early stage post-cardiac arrest period regard ability improve neurological outcome patient , compare standard care ( include hypothermia indicate ) .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Inclusion criterion : Age 18 80 Witnessed outofhospital cardiac arrest , presumed cardiac origin ( non asphyxic ) Time cardiac arrest recovery circulatory activity le 60 minute Persistent coma ROSC ( Coma Glasgow Scale &lt; 7 ) Exclusion criterion : Outofhospital cardiac arrest evidence extracardiac cause ( trauma , sepsis , acute respiratory insufficiency , asphyxia ) Previous chronic treatment erythropoietin analogue Pregnancy Rapidly fatal underlying disease ( expect life duration &lt; 6 month ) No social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Cardiac arrest</keyword>
	<keyword>erythropoietin</keyword>
	<keyword>post-anoxic encephalopathy</keyword>
	<keyword>neuroprotective drug</keyword>
</DOC>